NYSE:DGX Quest Diagnostics (DGX) Stock Price, News & Analysis $157.47 +10.10 (+6.85%) (As of 10/22/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About Quest Diagnostics Stock (NYSE:DGX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Quest Diagnostics alerts:Sign Up Key Stats Today's Range$151.33▼$159.1550-Day Range$146.83▼$156.9752-Week Range$120.87▼$159.36Volume2.04 million shsAverage Volume922,236 shsMarket Capitalization$17.49 billionP/E Ratio21.25Dividend Yield1.91%Price Target$154.92Consensus RatingHold Company OverviewQuest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.Read More… [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Quest Diagnostics Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks99th Percentile Overall ScoreDGX MarketRank™: Quest Diagnostics scored higher than 99% of companies evaluated by MarketBeat, and ranked 20th out of 998 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.2 / 5Analyst RatingHold Consensus RatingQuest Diagnostics has received a consensus rating of Hold. The company's average rating score is 2.31, and is based on 4 buy ratings, 9 hold ratings, and no sell ratings.Amount of Analyst CoverageQuest Diagnostics has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Quest Diagnostics' stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth8.77% Earnings GrowthEarnings for Quest Diagnostics are expected to grow by 8.77% in the coming year, from $8.89 to $9.67 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Quest Diagnostics is 21.25, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 131.83.Price to Earnings Ratio vs. SectorThe P/E ratio of Quest Diagnostics is 21.25, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 135.58.Price to Earnings Growth RatioQuest Diagnostics has a PEG Ratio of 2.45. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioQuest Diagnostics has a P/B Ratio of 2.79. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Quest Diagnostics' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.78% of the float of Quest Diagnostics has been sold short.Short Interest Ratio / Days to CoverQuest Diagnostics has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Quest Diagnostics has recently decreased by 18.60%, indicating that investor sentiment is improving significantly. Dividend4.2 / 5Dividend StrengthStrong Dividend YieldQuest Diagnostics pays a meaningful dividend of 2.01%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthQuest Diagnostics has been increasing its dividend for 13 years.Dividend CoverageThe dividend payout ratio of Quest Diagnostics is 40.38%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Quest Diagnostics will have a dividend payout ratio of 31.02% next year. This indicates that Quest Diagnostics will be able to sustain or increase its dividend.Read more about Quest Diagnostics' dividend. Sustainability and ESG4.7 / 5Environmental Score-0.62 Percentage of Shares Shorted1.78% of the float of Quest Diagnostics has been sold short.Short Interest Ratio / Days to CoverQuest Diagnostics has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Quest Diagnostics has recently decreased by 18.60%, indicating that investor sentiment is improving significantly. News and Social Media2.5 / 5News Sentiment0.53 News SentimentQuest Diagnostics has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 17 news articles for Quest Diagnostics this week, compared to 9 articles on an average week.Search InterestOnly 2 people have searched for DGX on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows2 people have added Quest Diagnostics to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Quest Diagnostics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $365,081.00 in company stock.Percentage Held by InsidersOnly 0.79% of the stock of Quest Diagnostics is held by insiders.Percentage Held by Institutions88.06% of the stock of Quest Diagnostics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Quest Diagnostics' insider trading history. Receive DGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Quest Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address DGX Stock News HeadlinesQuest Diagnostics Inc (DGX) Shares Up 6.22% on Oct 22October 22 at 12:07 PM | gurufocus.comQuest Revises Annual Outlook To Reflect Acquisitions, Expects Hurricane Impact In Q4October 22 at 10:37 AM | markets.businessinsider.com[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.October 22, 2024 | Crypto Swap Profits (Ad)Quest Diagnostics Q3 Profit Increases, Beats EstimatesOctober 22 at 10:37 AM | markets.businessinsider.comQuest Diagnostics beats quarterly results estimates on diagnostic test demandOctober 22 at 8:05 AM | reuters.comQuest Diagnostics Reports Third Quarter 2024 Financial Results; Updates Guidance for Full Year 2024October 22 at 6:45 AM | prnewswire.comLooking Into Quest Diagnostics's Recent Short InterestOctober 21 at 2:27 PM | benzinga.comQuest Diagnostics Incorporated (NYSE:DGX) Receives $154.92 Average PT from BrokeragesOctober 18, 2024 | americanbankingnews.comSee More Headlines DGX Stock Analysis - Frequently Asked Questions How have DGX shares performed this year? Quest Diagnostics' stock was trading at $137.88 at the start of the year. Since then, DGX stock has increased by 14.2% and is now trading at $157.47. View the best growth stocks for 2024 here. How were Quest Diagnostics' earnings last quarter? Quest Diagnostics Incorporated (NYSE:DGX) posted its earnings results on Tuesday, July, 23rd. The medical research company reported $2.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.31 by $0.04. The firm's quarterly revenue was up 2.5% compared to the same quarter last year. Read the conference call transcript. How will Quest Diagnostics' stock buyback program work? Quest Diagnostics' Board of Directors authorized a stock buyback program on Thursday, February 2nd 2023, which authorizes the company to repurchase $1,000,000,000 in shares, according to EventVestor. This means that the company could purchase up to 6% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's management believes its stock is undervalued. Does Quest Diagnostics have any subsidiaries? Quest Diagnostics subsidiaries include MACL, Blueprint Genetics, PhenoPath Laboratories, ReproSource, California Laboratory Associates, Cleveland HeartLab, Cape Cod Healthcare - Business, and others. Who are Quest Diagnostics' major shareholders? Top institutional shareholders of Quest Diagnostics include Wedge Capital Management L L P NC (0.22%), Copeland Capital Management LLC (0.18%), Raymond James & Associates (0.13%) and Willis Investment Counsel (0.11%). Insiders that own company stock include Stephen H Rusckowski, Catherine T Doherty, Michael E Prevoznik, Michael J Deppe, Timothy M Ring, Vicky B Gregg, Karthik Kuppusamy and Mark E Delaney. View institutional ownership trends. How do I buy shares of Quest Diagnostics? Shares of DGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Quest Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Quest Diagnostics investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Adobe (ADBE), General Electric (GE) and ServiceNow (NOW). Company Calendar Last Earnings7/23/2024Ex-Dividend for 10/21 Dividend10/04/2024Dividend Payable10/21/2024Today10/22/2024Next Earnings (Confirmed)10/22/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Medical laboratories Sub-IndustryHealth Care Services Current SymbolNYSE:DGX CUSIP74834L10 CIK1022079 Webwww.questdiagnostics.com Phone(973) 520-2700Fax201-462-4169Employees48,000Year Founded1967Price Target and Rating Average Stock Price Target$154.92 High Stock Price Target$165.00 Low Stock Price Target$135.00 Potential Upside/Downside0.0%Consensus RatingHold Rating Score (0-4)2.31 Research Coverage13 Analysts Profitability EPS (Most Recent Fiscal Year)$7.43 Trailing P/E Ratio20.91 Forward P/E Ratio17.43 P/E Growth2.45Net Income$854 million Net Margins8.99% Pretax Margin11.94% Return on Equity15.35% Return on Assets7.19% Debt Debt-to-Equity Ratio0.57 Current Ratio1.00 Quick Ratio0.91 Sales & Book Value Annual Sales$9.35 billion Price / Sales1.84 Cash Flow$13.25 per share Price / Cash Flow11.69 Book Value$56.41 per share Price / Book2.75Miscellaneous Outstanding Shares111,092,000Free Float110,438,000Market Cap$17.21 billion OptionableOptionable Beta0.89 Social Links The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NYSE:DGX) was last updated on 10/22/2024 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredElection rigged? We caught them red-handed…What happens if NOBODY will be elected the next President of the United States on Nov. 5? Not Donald Trump...Banyan Hill Publishing | SponsoredIt’s delivered 859% in 2.5 months…We’ve gotten a lot of messages asking… what should we buy if Trump wins? What should we buy if Kamala wins?...The Oxford Club | SponsoredFed Quietly Admits Gold is Replacing the DollarA major shift is occurring in the global financial system… The Fed has "quietly admitted" that Gold is repl...Gold Safe Exchange | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quest Diagnostics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Quest Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.